BioCentury
ARTICLE | Clinical News

Shire preclinical data

November 12, 2007 8:00 AM UTC

In rats, Dynepo corrected the reduction in nerve conduction velocity that is associated with neuropathy. The compound was given at doses below those that prompt hematopoiesis. Data on the gene-activat...